Jupiter Investment Management’s Haemonetics HAE Stock Holding History

Jupiter Investment Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-57,891	Closed	-$5.77M	–	432
2020 Q1	$5.77M	Sell	57,891 -41,503	-42%	-$4.5M	0.11%	151
2019 Q4	$11.4M	Buy	+99,394	New	+$12M	0.16%	154
2019 Q2	–	Sell	-261,865	Closed	-$22.9M	–	375
2019 Q1	$22.9M	Sell	261,865 -174,517	-40%	-$15.9M	0.21%	111
2018 Q4	$43.7M	Sell	436,382 -47,102	-10%	-$4.95M	0.39%	77
2018 Q3	$55.4M	Buy	483,484 +171,049	+55%	+$17.7M	0.38%	81
2018 Q2	$28M	Buy	+312,435	New	+$26.4M	0.2%	110

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jupiter Investment Management's HAE Position: Q2 2020 in Review

Jupiter Investment Management sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 57,891 shares — an estimated $5.77M sold.

Jupiter Investment Management first reported a position in HAE in Q2 2018 and held it in 6 quarters. The position peaked at $55.4M in Q3 2018. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

Jupiter Investment Management reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
Jupiter Investment Management sold 57,891 Haemonetics shares in Q2 2020, an estimated $5.77M.
Jupiter Investment Management first reported a position in Haemonetics in Q2 2018 and held it in 6 quarters.
Jupiter Investment Management's Haemonetics position peaked at $55.4M in Q3 2018.
285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.